{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:53:19Z","timestamp":1790563999481,"version":"4.1.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>Metastatic melanoma is a very aggressive form of cancer in both humans and dogs. Dogs primarily develop oral melanoma of mucosal origin. Although oral melanoma in humans is rare, both diseases are highly aggressive with frequent metastases. This disease represents a \u201cOne Health\u201d opportunity to improve molecular and mechanistic understanding of melanoma progression. Accumulating evidence suggests that cyclooxygenase-2 (COX-2) may play a critical role in the malignant behaviour of melanoma. In this study we analysed 85 histologically confirmed melanomas from canine patients and showed that COX-2 is overexpressed in both oral and cutaneous melanomas and that COX-2 expression correlates with established markers of poor prognosis. To determine the role of COX-2 in melanoma we developed two melanoma cell lines with stable integration of an inducible doxycycline-regulated expression vector containing a COX-2 targeted micro-RNA (miRNA). Using this system, we showed that cellular proliferation, migration and invasion are COX-2 dependent, establishing a direct relationship between COX-2 expression and malignant behaviour in canine melanoma. We have also developed a powerful molecular tool to aid further dissection of the mechanisms by which COX-2 regulates melanoma progression.<\/jats:p>","DOI":"10.3389\/fvets.2021.633170","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T16:26:59Z","timestamp":1630081619000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["COX-2 Silencing in Canine Malignant Melanoma Inhibits Malignant Behaviour"],"prefix":"10.3389","volume":"8","author":[{"given":"Tatiany L.","family":"Silveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Y.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Di Domenico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson S.","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ist\u00e9fani L. D.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen L. Del","family":"Puerto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enio","family":"Ferreria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Argyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/vetsci3010007","article-title":"Comparative aspects of canine melanoma","volume":"3","author":"Nishiya","year":"2016","journal-title":"Vet Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"500","DOI":"10.4065\/81.4.500","article-title":"Cutaneous malignant melanoma","volume":"81","author":"Cummins","year":"2006","journal-title":"Mayo Clin Proc."},{"key":"B3","doi-asserted-by":"publisher","first-page":"231693","DOI":"10.1155\/2012\/231693","article-title":"Rising incidence of mucosal melanoma of the head and neck in the united states","volume":"2012","author":"Marcus","year":"2012","journal-title":"J Skin Cancer."},{"key":"B4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/path.4632","article-title":"Cross-species models of human melanoma","volume":"238","author":"van","year":"2016","journal-title":"J Pathol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/CMR.0b013e32831d7f52","article-title":"Cox-2 expression in malignant melanoma: a novel prognostic marker?","volume":"19","author":"Becker","year":"2009","journal-title":"Melanoma Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.20892\/j.issn.2095-3941.2019.0339","article-title":"Cox-2 as a potential biomarker and therapeutic target in melanoma","volume":"17","author":"Tudor","year":"2020","journal-title":"Cancer Biol Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1177\/0300985810396517","article-title":"Cyclooxygenase-2 expression is related with localization, proliferation, and overall survival in canine melanocytic neoplasms","volume":"48","author":"Martinez","year":"2011","journal-title":"Vet Pathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2048731","DOI":"10.1155\/2016\/2048731","article-title":"Cyclooxygenase-2: a role in cancer stem cell survival and repopulation of cancer cells during therapy","volume":"2016","author":"Pang","year":"2016","journal-title":"Stem Cells Int."},{"key":"B9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.bbalip.2014.09.016","article-title":"Cyclooxygenase inhibitors: from pharmacology to clinical read-outs","volume":"1851","author":"Patrignani","year":"2015","journal-title":"Biochim Biophys Acta."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e83144","DOI":"10.1371\/journal.pone.0083144","article-title":"Global gene expression analysis of canine osteosarcoma stem cells reveals a novel role for cox-2 in tumour initiation","volume":"9","author":"Pang","year":"2014","journal-title":"PLoS ONE."},{"key":"B11","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/jama.2009.1825","article-title":"Aspirin use and survival after diagnosis of colorectal cancer","volume":"302","author":"Chan","year":"2009","journal-title":"JAMA."},{"key":"B12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.phrs.2012.02.003","article-title":"Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapy","volume":"66","author":"Hussain","year":"2012","journal-title":"Pharmacol Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4255\/mcpharmacol.09.05","article-title":"Anti-inflammatory agents for cancer therapy","volume":"1","author":"Rayburn","year":"2009","journal-title":"Mol Cell Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/bcpt.12162","article-title":"Characterization of microsomal prostaglandin e synthase 1 inhibitors","volume":"114","author":"Korotkova","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/vco.12470","article-title":"The selective cyclooxygenase-2 inhibitor mavacoxib (trocoxil) exerts anti-tumour effects in vitro independent of cyclooxygenase-2 expression levels","volume":"17","author":"Hurst","year":"2019","journal-title":"Vet Comp Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jcpa.2010.01.016","article-title":"Cox-1 and cox-2 expression in canine cutaneous, oral and ocular melanocytic tumours","volume":"143","author":"Pires","year":"2010","journal-title":"J Comp Pathol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/CMR.0000000000000262","article-title":"Investigating associations of cyclooxygenase-2 expression with angiogenesis, proliferation, macrophage and t-lymphocyte infiltration in canine melanocytic tumours","volume":"26","author":"Gregorio","year":"2016","journal-title":"Melanoma Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.rvsc.2014.03.003","article-title":"Antitumor effects of celecoxib in cox-2 expressing and non-expressing canine melanoma cell lines","volume":"96","author":"Seo","year":"2014","journal-title":"Res Vet Sci."},{"key":"B19","volume-title":"Histological Classification of Epithelial and Melanocytic Tumors of the Skin of Domestic Animals","author":"Goldschmidt","year":"1998"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0300985815593349","article-title":"Mitotic count and the field of view area: time to standardize","volume":"53","author":"Meuten","year":"2016","journal-title":"Vet Pathol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/0300985810390717","article-title":"Prognostic markers for canine melanocytic neoplasms: a comparative review of the literature and goals for future investigation","volume":"48","author":"Smedley","year":"2011","journal-title":"Vet Pathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.24070\/bjvp.1983-0246.v13i1p17-20","article-title":"Use of giemsa staining for the immunohistochemical counterstaining in canine melanomas: an \u201cold and forgotten\u201d method","volume":"13","author":"Silveira","year":"2020","journal-title":"Braz J Vet Pathol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/0300985810387447","article-title":"Immunohistochemical diagnosis of canine oral amelanotic melanocytic neoplasms","volume":"48","author":"Smedley","year":"2011","journal-title":"Vet Pathol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1354\/vp.08-VP-0226-C-FL","article-title":"Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival","volume":"46","author":"Lavalle","year":"2009","journal-title":"Vet Pathol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.humpath.2013.02.022","article-title":"Melanogenesis affects overall and disease-free survival in patients with stage iii and iv melanoma","volume":"44","author":"Brozyna","year":"2013","journal-title":"Hum Pathol."},{"key":"B27","first-page":"739","article-title":"Primary mucosal melanomas: a comprehensive review","volume":"5","author":"Mihajlovic","year":"2012","journal-title":"Int J Clin Exp Pathol."},{"key":"B28","first-page":"1005","article-title":"Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification","volume":"28","author":"Rastrelli","year":"2014","journal-title":"In Vivo."},{"key":"B29","first-page":"303","article-title":"Expression of cyclooxygenase 2 in human malignant melanoma","volume":"61","author":"Denkert","year":"2001","journal-title":"Cancer Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"713","DOI":"10.4161\/cbt.2.6.627","article-title":"Analysis of cyclooxygenase 2 (cox-2) expression during malignant melanoma progression","volume":"2","author":"Goulet","year":"2003","journal-title":"Cancer Biol Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/jop.12385","article-title":"Immunohistochemical expression of cyclooxygenase-2 (cox-2) in oral nevi and melanoma","volume":"45","author":"de","year":"2016","journal-title":"J Oral Pathol Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"364207","DOI":"10.1155\/2014\/364207","article-title":"Abnormal cox2 protein expression may be correlated with poor prognosis in oral cancer: a meta-analysis","volume":"2014","author":"Wang","year":"2014","journal-title":"Biomed Res Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.plefa.2003.10.002","article-title":"Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer","volume":"70","author":"Mohammed","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids."},{"key":"B34","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/vco.12601","article-title":"Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas","volume":"18","author":"Silveira","year":"2020","journal-title":"Vet Comp Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2353\/ajpath.2007.060769","article-title":"A reduction of cyclooxygenase 2 gene dosage counters the ovarian morphological aging and tumor phenotype in wv mice","volume":"170","author":"Yang","year":"2007","journal-title":"Am J Pathol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.3892\/or.18.6.1557","article-title":"Targeted inhibition of cox-2 expression by rna interference suppresses tumor growth and potentiates chemosensitivity to cisplatin in human gastric cancer cells","volume":"18","author":"Chan","year":"2007","journal-title":"Oncol Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/S0959-8049(01)00160-5","article-title":"Inhibitors of cyclooxygenase-2 (cox-2) suppressed the proliferation and differentiation of human leukaemia cell lines","volume":"37","author":"Nakanishi","year":"2001","journal-title":"Eur J Cancer."},{"key":"B38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/PREACCEPT-9511370941246208","article-title":"The long-acting cox-2 inhibitor mavacoxib (trocoxil) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro","volume":"10","author":"Pang","year":"2014","journal-title":"BMC Vet Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"215158","DOI":"10.1155\/2010\/215158","article-title":"The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies","volume":"2010","author":"Sobolewski","year":"2010","journal-title":"Int J Cell Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1476-5829.2011.00313.x","article-title":"Epithelial-mesenchymal transition as a fundamental mechanism underlying the cancer phenotype","volume":"11","author":"Cervantes-Arias","year":"2013","journal-title":"Vet Comp Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1517\/14728222.2014.860447","article-title":"Expression of cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness","volume":"18","author":"Bocca","year":"2014","journal-title":"Expert Opin Ther Targets."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1093\/carcin\/bgn202","article-title":"Cox-2 inactivates smad signaling and enhances emt stimulated by tgf-beta through a pge2-dependent mechanisms","volume":"29","author":"Neil","year":"2008","journal-title":"Carcinogenesis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1756-9966-33-40","article-title":"Restoration of e-cadherin expression by selective cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma","volume":"33","author":"Fujii","year":"2014","journal-title":"J Exp Clin Cancer Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.3748\/wjg.v19.i37.6265","article-title":"Interaction between cyclooxygenase-2, snail, and e-cadherin in gastric cancer cells","volume":"19","author":"Liu","year":"2013","journal-title":"World J Gastroenterol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"9328","DOI":"10.1158\/0008-5472.CAN-05-1343","article-title":"A tumorigenic subpopulation with stem cell properties in melanomas","volume":"65","author":"Fang","year":"2005","journal-title":"Cancer Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.ejca.2007.01.017","article-title":"Melanoma contains cd133 and abcg2 positive cells with enhanced tumourigenic potential","volume":"43","author":"Monzani","year":"2007","journal-title":"Eur J Cancer."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/jid.2010.69","article-title":"Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells","volume":"130","author":"Perego","year":"2010","journal-title":"J Invest Dermatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature06489","article-title":"Identification of cells initiating human melanomas","volume":"451","author":"Schatton","year":"2008","journal-title":"Nature."}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2021.633170\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T16:27:05Z","timestamp":1630081625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2021.633170\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":48,"alternative-id":["10.3389\/fvets.2021.633170"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2021.633170","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"article-number":"633170"}}